Antisickling effects of an endogenous human α-like globin

Nature Medicine

Volumn 10, Issue 4, 2004, Pages 365-367

  He, Zhenning ^a   Russell, J Eric ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN C; HEMOGLOBIN CHAIN; HEMOGLOBIN S; UNCLASSIFIED DRUG; ZETA GLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; ERYTHROPOIESIS; GENE REPLACEMENT THERAPY; HEMATOCRIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; PHENOTYPE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; SPLENOMEGALY; TRANSGENIC MOUSE;

ANIMALS; ANTISICKLING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLOBINS; HUMANS; MICE; MICE, TRANSGENIC;

ANIMALIA; MUS MUSCULUS;

EID: 1942454348     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1022     Document Type: Article

References (12)

1. Bunn, H.F. & Forget, B.G. in Hemoglobin: Molecular, Genetic, and Clinical Aspects 502-564 (W.B. Saunders, Philadelphia, 1986).
2. Pastzy, C. et al. Science 278, 876-879 (1997).
3. Liebhaber, S.A. et al. Mol. Cell. Biol. 16, 2637-2646 (1996).
4. Chang, J. et al. Blood 88, 1846-1851 (1996).
5. He, Z. & Russell, J.E. Anal. Biochem. 349-352 (2002).
6. Edelstein, S.J. J. Mol. Biol. 150, 557-575 (1981).
7. Huang, B.L. et al. Proc. Natl. Acad. Sci. USA 95, 14669-14674 (1998).
8. Liu, J.-J., Hou, S.-C. & Shen, C.-K.J. J. Biol. Chem. 278, 19534-19540 (2003).
9. Wang, Z. & Liebhaber, S.A. EMBO J. 18, 2218-2228 (1999).
10. Chui, D.H.K. et al. N. Engl. J. Med. 314, 76-79 (1986).
11. Tang, W. et al. Blood 81, 1636-1640 (1993).
12. Papayannopoulou, T. et al. Blood 77, 2569-2576 (1991).